• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Personalised approach in follicular lymphoma.

作者信息

Luminari Stefano

机构信息

Hematology Unit, Azienda Unità Sanitaria Locale-IRCCS Reggio Emilia, 42123, Italy; Surgical, Medical and Dental Department of Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Reggio Emilia, Italy.

出版信息

Lancet Oncol. 2018 Nov;19(11):1431-1432. doi: 10.1016/S1470-2045(18)30688-0. Epub 2018 Oct 8.

DOI:10.1016/S1470-2045(18)30688-0
PMID:30309757
Abstract
摘要

相似文献

1
Personalised approach in follicular lymphoma.滤泡性淋巴瘤的个性化治疗方法。
Lancet Oncol. 2018 Nov;19(11):1431-1432. doi: 10.1016/S1470-2045(18)30688-0. Epub 2018 Oct 8.
2
Immunotherapy for patients with follicular lymphoma: the contribution of systematic reviews.滤泡性淋巴瘤患者的免疫治疗：系统评价的贡献。
Acta Haematol. 2011;125(1-2):23-31. doi: 10.1159/000318883. Epub 2010 Dec 8.
3
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.在接受一线免疫化疗的滤泡性淋巴瘤患者中，基因突变更新预后风险预测：一项前瞻性临床试验的回顾性分析及基于人群的登记处验证。
Lancet Oncol. 2015 Sep;16(9):1111-1122. doi: 10.1016/S1470-2045(15)00169-2. Epub 2015 Aug 6.
4
67 Gallium in the detection and localization of tumours.
S Afr Med J. 1971 Dec 11;45(47):1351-9.
5
Efficacy and safety of obinutuzumab in patients with previously untreated follicular lymphoma: a subgroup analysis of patients enrolled in Japan in the randomized phase III GALLIUM trial.奥妥珠单抗治疗初治滤泡性淋巴瘤患者的疗效与安全性：在日本入组随机III期GALLIUM试验患者的亚组分析
Int J Hematol. 2018 Nov;108(5):499-509. doi: 10.1007/s12185-018-2497-0. Epub 2018 Jul 19.
6
Update on front-line therapy for follicular lymphoma: chemo-immunotherapy with rituximab and survival.滤泡性淋巴瘤一线治疗的最新进展：利妥昔单抗化疗免疫疗法与生存情况
Expert Rev Anticancer Ther. 2007 Jul;7(7):959-65. doi: 10.1586/14737140.7.7.959.
7
Cellular immunotherapy for follicular lymphoma using genetically modified CD20-specific CD8+ cytotoxic T lymphocytes.使用基因改造的CD20特异性CD8 + 细胞毒性T淋巴细胞进行滤泡性淋巴瘤的细胞免疫治疗。
Mol Ther. 2004 Apr;9(4):577-86. doi: 10.1016/j.ymthe.2003.12.011.
8
[Current treatment strategies for follicular lymphoma].[滤泡性淋巴瘤的当前治疗策略]
Internist (Berl). 2016 Mar;57(3):222-9. doi: 10.1007/s00108-015-0009-3.
9
Follicular lymphoma: a therapeutic update.滤泡性淋巴瘤：治疗进展
Bull Cancer. 2005 Oct;92(10):E57-64.
10
Idiotype vaccine strategies for treatment of follicular lymphoma.针对滤泡性淋巴瘤的独特型疫苗治疗策略。
Future Oncol. 2011 Jan;7(1):111-22. doi: 10.2217/fon.10.159.

引用本文的文献

1
Total Metabolic Tumor Volume Is a Strong Independent Prognostic Factor in Follicular Lymphomas: Results From a Sub-Study of the FOLL12 Trial.总代谢肿瘤体积是滤泡性淋巴瘤的一个强有力的独立预后因素：FOLL12试验子研究的结果
Am J Hematol. 2025 Jul;100(7):1196-1204. doi: 10.1002/ajh.27711. Epub 2025 May 14.
2
Prognostic role of interim PET in follicular lymphoma: a post hoc study of FOLL12 trial by Fondazione Italiana Linfomi.中期PET在滤泡性淋巴瘤中的预后作用：意大利淋巴瘤基金会对FOLL12试验的事后分析
Blood Adv. 2025 Jun 24;9(12):2927-2934. doi: 10.1182/bloodadvances.2024014790.
3
Prognostic Significance of Interim PET/CT in the First-Line Treatment of Follicular Lymphoma Patients, a Single-Center Experience.
中期PET/CT在滤泡性淋巴瘤患者一线治疗中的预后意义：单中心经验
Cancers (Basel). 2024 Dec 29;17(1):73. doi: 10.3390/cancers17010073.
4
Follicular Lymphoma: Diagnostic and Prognostic Considerations in Initial Treatment Approach.滤泡性淋巴瘤：初始治疗方法中的诊断和预后考虑因素。
Curr Oncol Rep. 2019 May 23;21(7):63. doi: 10.1007/s11912-019-0808-0.